The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 1,741 | 15,643 | 4,242 | 6,152 |
| Depreciation and amortization | 1,595 | 1,577 | 1,535 | 2,773 |
| Amortization of deferred loan costs | 62 | 59 | 52 | 104 |
| Share-based compensation | 1,227 | 1,209 | 2,159 | 2,837 |
| Provision for inventory obsolescence | -22 | 367 | 299 | 191 |
| Deferred income tax expense | 377 | -9,250 | -317 | -1,398 |
| Gain on sale of property and equipment | 47 | -5 | 26 | 475 |
| Change in fair value of contingent consideration | - | 156 | - | - |
| Provision for credit losses | 0 | -22 | -25 | 19 |
| Net foreign currency unrealized loss (gain) | -183 | 431 | -592 | 1,854 |
| Proceeds from note receivable | - | 0 | 0 | 0 |
| Accounts receivabletrade | -4,524 | 4,103 | -431 | 1,827 |
| Inventories, net | 1,999 | -4,997 | 1,312 | 1,476 |
| Prepaid expenses and other assets | -238 | -833 | -2,182 | -972 |
| Accounts payabletrade | 1,963 | 878 | -2,170 | 1,719 |
| Accrued expenses | -4,560 | 1,034 | 1,365 | -1,680 |
| Other liabilities | -3,727 | -549 | -1,325 | -4,101 |
| Income taxes receivable/payable | -275 | 728 | -514 | -80 |
| Net cash provided by (used in) operating activities | 1,280 | 13,131 | 7,168 | 1,876 |
| Purchases of property and equipment | 591 | 225 | 231 | 745 |
| Purchase and development of software and technology | 48 | 45 | 61 | 0 |
| Proceeds from sales of property and equipment | 80 | 37 | 464 | 271 |
| Acquisition of business, net of cash acquired | - | 0 | 5,758 | - |
| Proceeds from company-owned life insurance policy | - | 0 | - | - |
| Net cash used in investing activities | -559 | -233 | -5,586 | -474 |
| Payments on finance leases | 613 | 596 | 554 | 1,072 |
| Line of credit borrowings | 1,970 | 0 | 0 | 2,338 |
| Payments of line of credit borrowings | 1,970 | 0 | 0 | 2,338 |
| Distribution to non-controlling interest | - | 800 | 1,000 | 900 |
| Payment of contingent consideration | 1,250 | - | - | - |
| Payment of deferred loan cost related to abl facility | - | 55 | - | - |
| Treasury shares withheld | 1,074 | 58 | 0 | 268 |
| Net cash used in financing activities | -2,937 | -1,509 | -1,554 | -2,240 |
| Effect of exchange rate changes on cash and cash equivalents | -51 | 41 | -105 | 330 |
| Net change in cash and cash equivalents | -2,267 | 11,430 | -77 | -508 |
| Cash and cash equivalents beginning of period | 36,725 | 25,295 | 25,880 | - |
| Cash and cash equivalents end of period | 34,458 | 36,725 | 25,295 | - |